Welcome to our dedicated page for SPLASH BEVERAGE GROUP SEC filings (Ticker: SBEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Splash Beverage Group, Inc. filings document the regulatory record of a Nevada beverage operating company with common stock listed on NYSE American under SBEV. Its disclosures include Form 8-K material-event reports, periodic reporting notices, capital-structure items, shareholder voting matters, and governance updates.
The company's filings cover material agreements such as settlement amendments, board appointments and resignations, compensatory arrangements, equity-plan related grants, and amendments to its charter documents. Capital-structure disclosures include common stock registration details and the withdrawal of a Series A Preferred Stock designation. Reporting records also include annual-report timing disclosures and operating or financial-result categories tied to the company's beverage-brand portfolio.
Splash Beverage Group, Inc. entered into amendments to settlement agreements with three prior investors, extending the schedule for remaining settlement payments. The company agreed that 50% of the remaining unpaid settlements, or $137,797.54, would be paid on July 15, 2026, which was paid that day.
The remaining 50%, also $137,797.54, is due on July 31, 2026, with interest accruing at 12% per annum plus reasonable attorney’s fees for the investors. These amendments revise February 2026 settlements related to amounts invested by the investors in October 2024.
Splash Beverage Group approved a structural change to its stock and disclosed a trading halt. The company filed a Certificate of Change in Nevada to implement a one-for-four reverse stock split of its issued and outstanding common shares, effective at 4:30 p.m. Eastern Time on July 24, 2026. Authorized common shares will be reduced proportionally from 400,000,000 to 100,000,000, and all options, warrants and restricted stock tied to the common will be adjusted accordingly. The common stock will receive a new CUSIP, 84862C401.
On July 16, 2026, NYSE American halted trading in the company’s stock because it was trading below $0.10 per share; the last trading price before the halt was $0.0936. The company expects trading to resume on a reverse stock split–adjusted basis when the market opens on July 27, 2026, while cautioning about the risk of potential delisting and the possibility that the halt may not be lifted as anticipated.
Splash Beverage Group, Inc. announced two major steps in its ongoing financial and listing-compliance strategy. The company has negotiated settlements with multiple legacy creditors covering approximately $3.3 million of accounts payable and accrued liabilities for aggregate cash consideration of approximately $550,000. Subject to final accounting review, Splash expects to recognize an approximate $2.75 million gain from the extinguishment of indebtedness, eliminating about 84% of the negotiated obligations while paying roughly 17% of their face value.
The Board of Directors also approved a 1-for-4 reverse stock split of issued and outstanding common stock, effective after the market closes on July 24, 2026, with post-split trading beginning July 27, 2026. The reverse split is intended to support continued compliance with NYSE American minimum share price requirements and is a key part of the exchange-approved compliance plan. Management highlights these actions, along with recent strategic investments and licensing deals, as elements of a broader transformation toward a cannabinoid health, wellness, and biopharmaceutical platform.
Splash Beverage Group, Inc. entered into a letter agreement with Decathlon Alpha IV, L.P., the lender under its Revenue Loan and Security Agreement dated December 24, 2020. The parties agreed that Splash may satisfy outstanding obligations of $2,834,689 under that loan by paying $301,800.55 on or before August 31, 2026.
Upon the lender’s receipt of this payment by that date, Splash will be irrevocably and unconditionally released and discharged from all obligations and claims arising out of the loan, including the remaining outstanding balance, fees, damages, costs, and expenses.
Splash Beverage Group, Inc. reported that from June 30, 2026 through July 8, 2026 it sold and issued 9,232,047 shares of common stock to C/M Capital Master Fund, LP under a previously disclosed Securities Purchase Agreement dated September 19, 2025, referred to as the ELOC Agreement.
These issuances generated total gross proceeds of $1,265,063. The company states that, to the extent the issuances are deemed unregistered, they relied on exemptions from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b). The purchaser’s resales of the shares are covered by a registration statement on Form S-1 (File No. 333-296755), which became effective on June 22, 2026.
Splash Beverage Group reports that NYSE American has accepted its plan to regain compliance with the exchange’s continued listing standards, giving the company until January 29, 2027 to meet shareholders’ equity requirements. The company’s common stock will continue trading on NYSE American under the ticker “SBEV” during this compliance period, so there is no immediate impact on the listing.
The company notes that failure to regain compliance or to make sufficient progress under the plan could lead the exchange to initiate delisting proceedings after the compliance period. Management highlights recent steps in a strategic transition toward a cannabinoid health, wellness, and biopharmaceutical platform, including an equity line facility, a strategic investment in Avicanna, and exclusive worldwide licensing rights to CannEpil®, which they intend to use to improve liquidity and balance sheet strength while pursuing the new business focus.
Splash Beverage Group entered an Exclusive License Agreement with Argent Biopharma for worldwide rights to CannEpil, a cannabinoid-based treatment for drug‑resistant epilepsy and related seizure disorders. Splash will pay the licensor a 15% royalty on net revenue for at least 10 years in each country or until the last patent there expires, and Argent can manufacture the product under future supply and quality agreements.
The company committed to use commercially reasonable efforts to start a Phase I trial within 24 months, a Phase II trial within 48 months, and to file a New Drug Application after successful trials. As part of the deal, Splash will issue 5,500 shares of Series D Convertible Preferred Stock with a total stated value of $5.5 million in exchange for cancellation of Argent’s notes. C/M Capital Partners agreed to invest at least $1 million in Splash within 60 days and may receive a $1 million sales bonus once CannEpil reaches $5 million in cumulative net revenue. The Series D authorizes 5,500 shares at $1,000 stated value each, convertible at $0.25 per share, with a $0.15 floor and a 4.99% beneficial ownership limit that can increase to 9.99%.
Splash Beverage Group has entered an exclusive worldwide licensing agreement with Argent BioPharma for CannEpil, a cannabinoid-based investigational therapy for drug-resistant epilepsy. CannEpil already has regulated patient access and reimbursement-supported use in markets such as Ireland, the United Kingdom, Germany and Australia under EU-GMP standards.
Under the deal, Splash receives global rights to develop, commercialize, market, distribute, sublicense and sell CannEpil for drug-resistant epilepsy, seizure disorders and related neurological conditions for an initial twenty-year term, including future improvements and reformulations. Consideration includes forgiveness of approximately $5 million of Argent BioPharma indebtedness and $5.5 million of newly issued Splash preferred equity, plus a 15% royalty on net revenue from worldwide CannEpil sales. An affiliate, C/M Capital Partners, has also committed a $1 million strategic investment to support regulatory, clinical and commercialization efforts.
Splash Beverage Group, Inc. reported an unregistered sale of equity under an existing purchase agreement. On June 24, 2026, the company sold and issued 767,953 shares of common stock to C/M Capital Master Fund, LP for gross proceeds of $117,036 under a Securities Purchase Agreement dated September 19, 2025.
The company states that these sales rely on exemptions from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b). The purchaser’s resales of these shares are covered by a registration statement on Form S-1 (File No. 333-296755), which became effective on June 22, 2026.
Splash Beverage Group, Inc. registers 10,000,000 shares of Common Stock for resale by C/M Capital Master Fund, LP pursuant to an equity line of credit Purchase Agreement.
The resale prospectus states the Company will not receive proceeds from secondary sales by C/M, although the Company may receive up to $32,164,892 in aggregate gross proceeds from sales of shares to C/M under the Purchase Agreement.
Shares outstanding are listed as 15,389,840 prior and 25,389,840 following issuance assuming full issuance of the registered shares.